Get Started

COGT

NASD Cogent Biosciences, Inc.
Oct 29, 2026 · 1:21 PM ET DELAYED Market Open

$32.09 ↓ -0.14 (-0.43%) Trading Down from the previous close of $32.23, $0.77 below the day’s high of $32.86

YTD change
-9.66%
vs 20-day SMA
+5.13%
vs 200-day SMA
-10.25%

Price ranges

Previous day
$31.68 $32.68
open $31.77 close $32.23
+$0.46 (+1.45%)
Today
$32.05 $32.86
open $32.86 now $32.09
-$0.77 (-2.34%)
Past week
$30.33 $32.68
from $31.43 now $32.09
+$0.66 (+2.10%)
Past month
$27.74 $32.68
from $32.02 now $32.09
+$0.07 (+0.22%)
This year
$27.74 $43.39
from $35.52 now $32.09
-$3.43 (-9.66%)

Price & Performance

-3.64 (-10.15%) / 6M

$26.91$32.61$38.32$44.02Apr 29Jul 30Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 26.6% away from all-time highs of $43.73
  • COGT is down 10% since the beginning of the year
  • COGT is up 101% over the past 12 months
  • COGT is up 0% over the past 1 month
  • 10% of all COGT investors are betting against COGT

COGT reads very good: price sits above one of the two key moving averages, the 12-month move is +101.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.52
Earnings momentum +6.7% Quarterly EPS growth
Quarterly change +6.7%

Valuation

P/E ratio N/A
Enterprise value $5.0B
Beta 0.88

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$792.3M
Debt$244.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $6.0B

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $451.83 +0.87%
MRNA Moderna, Inc. $214.17 +2.98%
RVMD Revolution Medicines, Inc. $188.72 +1.34%
ROIV Roivant Sciences Ltd. $37.11 +1.56%
BNTX BioNTech SE Sponsored ADR $87.99 +1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.